Results 101 to 110 of about 2,375 (156)

Gallium Resistance in <i>Staphylococcus aureus</i>: Polymorphisms and Morphology Impacting Growth in Metals, Antibiotics and Polyfluorinated Compounds. [PDF]

Appl Microbiol (Basel)
Ewunkem A, Simpson F, Holland D, Bowers T, Bailey A, Gore J, Iloghalu U, Williams V, Adjei-Fremah S, Kiki L, Justice B.   +10 more
europepmc   +1 more source

Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets. [PDF]

Heliyon
Li X, He M, Yi X, Lu X, Zhu M, Xue M, Tang Y, Zhu Y.   +7 more
europepmc   +1 more source

From ancient herb to modern miracle: an in-depth analysis of the cardioprotective effects of artemisinin and its derivatives. [PDF]

J Geriatr Cardiol
Li HS, Li SR, Liu WJ, Zhang Y, Wu R, Cui XY, Sun JZ, Ma YW, Zhao Y.   +8 more
europepmc   +1 more source

Key to Opening Kidney for Extrapolation Entrance in Health and Disease: Part I: Systems and Physiological Data [PDF]

core   +1 more source

The Potential Therapeutic Applications of Natural Products in the Oxidative Stress-Related MVA Pathway: Focus on HMGCR. [PDF]

Antioxidants (Basel)
Teng YN.
europepmc   +1 more source

Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives. [PDF]

Front Pharmacol
Xu L, Cao X, Deng Y, Zhang B, Li X, Liu W, Ren W, Tang X, Kong X, Zhang D.   +9 more
europepmc   +1 more source

Research advances in current drugs targeting hyperlipidemia (Review). [PDF]

Mol Med Rep
Zhao H, Wang Y, Li Y, Cheng R, Chen W.
europepmc   +1 more source

The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease. [PDF]

Hepatol Commun
Li Z, Zheng D, Zhang T, Ruan S, Li N, Yu Y, Peng Y, Wang D, Wang D.   +8 more
europepmc   +1 more source

Nanomedicine-enabled disruption of glucose metabolism and synergistic antitumor therapy. [PDF]

J Nanobiotechnology
Ni J, Ma A, Gao Q, Li C, Li D, Wang R, Ding Y, Cao H.   +7 more
europepmc   +1 more source

A Possible Recently Identified Evolutionary Strategy Using Membrane-Bound Vesicle Transfer of Genetic Material to Induce Bacterial Resistance, Virulence and Pathogenicity in Klebsiella oxytoca. [PDF]

Int J Mol Sci
Tamayo-Ordóñez YJ, Rosas-García NM, Bello-López JM, Tamayo-Ordóñez MC, Tamayo-Ordóñez FA, Calzada-Mendoza CC, Ayil-Gutiérrez BA.   +6 more
europepmc   +1 more source